A Clinical Efficacy of PRRT in Patients with Advanced, Nonresectable, Paraganglioma-Pheochromocytoma, Related to SDHx Gene Mutation

Paragangliomas and pheochromytomas (PPGLs) exhibit variable malignancy, advanced/hormonally active/progressive need therapy. PRRT (Peptide Receptor Radionuclide Therapy) could be an option for these patients. To evaluate the effectiveness of PRRT (90Y DOTATATE), based on overall survival (OS) and pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolasinska-Ćwikła, Agnieszka, Pęczkowska, Mariola, Ćwikła, Jarosław B., Michałowska, Ilona, Pałucki, Jakub M., Bodei, Lisa, Lewczuk-Myślicka, Anna, Januszewicz, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678858/
https://www.ncbi.nlm.nih.gov/pubmed/31262070
http://dx.doi.org/10.3390/jcm8070952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678858/
https://www.ncbi.nlm.nih.gov/pubmed/31262070
http://dx.doi.org/10.3390/jcm8070952

Ejemplares similares